CD163 and gastric cancer: Based on Cox regression analyses on CD16- and CD163-related factors in gastric cancer, tumor size, differentiation, invasion depth, lymph node metastasis, TNM stage, CD16 and CD163 macrophage densities were the independent prognostic factors for gastric cancer patients, and the difference was statistically significant (P < .05).